NATCO PHARMA
Back to Income Statement
|
NATCO PHARMA Last 5 Year Profit Before Tax History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Profit Before Tax | ₹2,291 Cr | ₹1,674 Cr | ₹862 Cr | ₹202 Cr | ₹580 Cr |
What is the latest Profit Before Tax of NATCO PHARMA ?
Year | Profit Before Tax |
---|---|
Mar2025 | ₹2,291 Cr |
Mar2024 | ₹1,674 Cr |
Mar2023 | ₹862 Cr |
Mar2022 | ₹202 Cr |
Mar2021 | ₹580 Cr |
How is Profit Before Tax of NATCO PHARMA Trending?
Years | Profit Before Tax | % Change | |
---|---|---|---|
Mar2025 | ₹2,291 Cr | 36.92 | |
Mar2024 | ₹1,674 Cr | 94.16 | |
Mar2023 | ₹862 Cr | 326.26 | |
Mar2022 | ₹202 Cr | -65.11 | |
Mar2021 | ₹580 Cr | - |
Compare Profit Before Tax of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹15,484.1 Cr | 1.4% | -1.9% | -42.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,451.0 Cr | 2.1% | 0.3% | -9.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,727.0 Cr | -0% | 1.1% | 13.4% | Stock Analytics | |
CIPLA | ₹124,533.0 Cr | -1.1% | -3.2% | -4.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,673.0 Cr | 3.4% | 0.2% | 8.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,629.0 Cr | -0.7% | 2% | 0.7% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | 1.4% |
-1.9% |
-42.6% |
SENSEX | 0.5% |
0.4% |
-1.1% |
You may also like the below Video Courses